More than 90% of PDAC tumors harbor mutations in the Kirsten Ras (KRAS) oncogene, while mutations in three tumor suppressor genes — TP53, CDKN2A/B, and SMAD4 — occur with frequencies of 30%–70%. Here, KRAS is linked to neoplasm.